BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $328.5 million in its fourth quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.54.
The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.07 per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $263.8 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $263.9 million.
For the year, the company reported a loss of $1.28 billion, or $6.42 per share. Revenue was reported as $606.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
